We search for latent needs and requirements directly on the market for the purpose of designing, developing and producing, in a timely manner, devices that are increasingly innovative.
We work nonstop on many products, the result of our continuous R&D efforts and of our collaboration with top names in the sector.
Device used to administer nutritional fluids directly through the abdominal wall of patients who, for various reasons, are unable to swallow. Implanted in the patient’s abdomen, the device consists of a plastic tube fitted with an internal stop system to prevent it from moving and of an external fitting for connection to the nutritional set. Intended for patients.
Medical device that makes it possible to avoid deviation of the rectum and the subsequent re-establishment of the natural way.
About 10-15% of all colon-rectum resections require temporary protection of the anastomosis from the passing of faeces. This procedure consists in creating an artificial anus by externalizing either the remaining ileum (ileostomy) or colon (colostomy) on the abdominal wall. In both cases, the patient will be discharged after an hospital stay of at least one week with a bag for collection of the faeces, which the patient will have to keep for at least two months. This will be followed by another hospital stay during which the patient will undergo another surgery for the “rechanneling” (eliminating the artificial anus and restoring continuity of the entire intestine). Other problems associated with ileostomies and colostomies are parastomal hernias.
The probe being developed will allow the creation of a temporary protective ileostomy percutaneously.
The last loop of the small intestine is inserted; then, small balloon is inflated to occlude the natural path of the faeces, which are channelled into the probe and collected inside a bag.
After about 7-9 days (with the patient still in the hospital), the probe is removed and the patient is discharged with no external collection bag.
The potential advantages of using this device for the patients are that they will not have to undergo another rechanneling surgery or wear a colostomy bag. As for the surgeon, the advantages are that he will not have to perform another surgery on the patient, leaving the operating room as well as the ward for oncologic diseases free for other patients. The ASLs (Local Healthcare Agency) also benefit from this device as they will be able to achieve significant cost savings since only one surgery is needed, the bags are not needed and no assistance needs to be provided, unlike with patients with colostomy bags.
Injector for means of contrast applied during diagnostic ultrasound scans aimed at detecting the presence of tumour cells, in particular during investigations of liver and prostate.
This electro-medical device has obtained two patents: one for the device and a second one, equally important, for the dedicated consumable.
Innovative and exclusive medical device intended for the reconstruction of an oesophagus damaged due to ingestion of caustic substances.
The device is designed for the following purposes:
- Reconstructing the oesophageal wall in paediatric patients that has been severely damaged as a result of the ingestion of caustic substances, such as sodium hypochlorite (bleach) and other products found in the home.
In case of no intervention using a suitable medical device, the wall is unable to reconstruct itself, with all the ensuing consequences, in the long run.
The device is basically made up of:
– an enteral feeding probe, since the damaged part of the oesophagus cannot, in the initial phase, be subjected to contact with substances such as food or other substances of any nature;
– at the level of the damage oesophageal wall, the probe is equipped with a “small balloon” having suitable shape, dimension and physical nature;
The product must be made using materials certified as being “implantable”, since the presence of the probe entails an implanted period of a couple of months, which amply exceeds the 30-day limit set by the standard for considering a product as non-implantable.
After a certain time period, the patient starts to partially ingest food no longer through the feeding tube, but rather through the natural way, in other words the food passes between the external wall of the stent, which is smaller than the oesophagus, and the oesophagus itself.
On what principle is the gradual reconstruction of the damaged wall is based: peristaltic effect carried out by the stent due to the peristalsis of the stomach/oesophagus system.
SIDAM is also collaborating with other companies for the development of post-transplant products.
We are talking about the development of an innovative system of specialist circuits for post-transplant treatment aimed at preserving and maintaining the physiological characteristics of internal organs, in particular liver, kidney and lung.
Development, in collaboration with another Italian company, of an electro-medical system and a disposable medical device for the separation and selection of stem cells.
In the biomedical sector, patents represent an important added value. SIDAM promotes and safeguards its inventions.
At present, we have many patents in 19 different count
We have the possibility to collaborate with the greatest experts in the sector at the global level. It is also thanks to these experts that our projects take shape.